Answers are grounded in this paper and cite their sources.
The risk of a subsequent cSCC steeply rises with the number of prior cSCCs and immune status, while the time interval decreases. This can support more informed decisions about follow-up management.
No takes yet. Share an insight, caveat, or question.
Eggermont et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: